WallStreetZen

NYSE: VAPO
Vapotherm Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for VAPO

Based on 2 analysts offering 12 month price targets for Vapotherm Inc.
Min Forecast
$37.00+43.36%
Avg Forecast
$40.00+54.98%
Max Forecast
$43.00+66.6%

Should I buy or sell VAPO stock?

Based on 3 analysts offering ratings for Vapotherm Inc.
Strong Buy
Strong Buy
3 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Forecast return on equity

Is VAPO forecast to generate an efficient return?
Company
-49.38%
Industry
22.99%
Market
1,975.19%
VAPO's Return on Equity is forecast to be low in 3 years (-49.38%); analysts are not confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is VAPO forecast to generate an efficient return on assets?
Company
-26.46%
Industry
11.68%
Market
951.37%
VAPO is forecast to generate lower Return on Assets (-26.46%) than the US Medical Devices industry average (11.68%)
Forecast

VAPO earnings per share forecast

What is VAPO's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$2.22-0.89%
Avg 2 year Forecast
-$2.11-5.8%
Avg 3 year Forecast
-$1.77-20.98%

VAPO revenue forecast

What is VAPO's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$102.9M-17.25%
Avg 2 year Forecast
$94.6M-23.93%
Avg 3 year Forecast
$110.2M-11.45%
VAPO's revenue is forecast to grow at a rate of -9.7% per year, which is not exceptional
Forecast

VAPO revenue growth forecast

How is VAPO forecast to perform vs Medical Devices companies and vs the US market?
Company
-9.7%
Industry
7.89%
Market
14.64%
VAPO's revenues are forecast to grow slower (-9.7% per year) than the US Medical Devices industry average (7.89%)
Forecast
VAPO's revenues are forecast to grow slower (-9.7% per year) than the US market average (14.64%)
Forecast

Vapotherm Stock Forecast FAQ

Is Vapotherm Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NYSE: VAPO) stock is to Strong Buy VAPO stock.

Out of 3 analysts, 3 (100%) are recommending VAPO as a Strong Buy, 0 (0%) are recommending VAPO as a Buy, 0 (0%) are recommending VAPO as a Hold, 0 (0%) are recommending VAPO as a Sell, and 0 (0%) are recommending VAPO as a Strong Sell.

What is VAPO's earnings growth forecast for 2021-2023?

(NYSE: VAPO) Vapotherm's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 36.72%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 22.98%.

Vapotherm's earnings in 2021 is -$57,300,000.On average, 3 Wall Street analysts forecast VAPO's earnings for 2021 to be $-57,735,280, with the lowest VAPO earnings forecast at $-59,035,624, and the highest VAPO earnings forecast at $-55,134,592. On average, 3 Wall Street analysts forecast VAPO's earnings for 2022 to be $-54,874,523, with the lowest VAPO earnings forecast at $-56,955,074, and the highest VAPO earnings forecast at $-51,493,628.

In 2023, VAPO is forecast to generate $-46,032,183 in earnings, with the lowest earnings forecast at $-46,032,183 and the highest earnings forecast at $-46,032,183.

What is VAPO's revenue growth forecast for 2021-2023?

(NYSE: VAPO) Vapotherm's forecast annual revenue growth rate of -9.7% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.89%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.64%.

Vapotherm's revenue in 2021 is $124,399,000.On average, 2 Wall Street analysts forecast VAPO's revenue for 2021 to be $2,677,278,570, with the lowest VAPO revenue forecast at $2,660,504,131, and the highest VAPO revenue forecast at $2,694,053,010. On average, 2 Wall Street analysts forecast VAPO's revenue for 2022 to be $2,460,979,325, with the lowest VAPO revenue forecast at $2,399,290,998, and the highest VAPO revenue forecast at $2,522,667,651.

In 2023, VAPO is forecast to generate $2,864,736,183 in revenue, with the lowest revenue forecast at $2,864,736,183 and the highest revenue forecast at $2,864,736,183.

What is VAPO's forecast return on assets (ROA) for 2021-2023?

(NYSE: VAPO) forecast ROA is -26.46%, which is lower than the forecast US Medical Devices industry average of 11.68%.

What is VAPO's Price Target?

According to 2 Wall Street analysts that have issued a 1 year VAPO price target, the average VAPO price target is $40.00, with the highest VAPO stock price forecast at $43.00 and the lowest VAPO stock price forecast at $37.00.

On average, Wall Street analysts predict that Vapotherm's share price could stay at $40.00 by Sep 8, 2022. The average Vapotherm stock price prediction forecasts a potential downside of N/A from the current VAPO share price of $25.81.

What is VAPO's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: VAPO) Vapotherm's current Earnings Per Share (EPS) is -$2.24. On average, analysts forecast that VAPO's EPS will be $-2.22 for 2021, with the lowest EPS forecast at $-2.27, and the highest EPS forecast at $-2.12. On average, analysts forecast that VAPO's EPS will be $-2.11 for 2022, with the lowest EPS forecast at $-2.19, and the highest EPS forecast at $-1.98. In 2023, VAPO's EPS is forecast to hit $-1.77 (min: $-1.77, max: $-1.77).

What is VAPO's forecast return on equity (ROE) for 2021-2023?

(NYSE: VAPO) forecast ROE is -49.38%, which is considered weak.
©2021 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.